Prescient Therapeutics Limited (AU:PTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Prescient Therapeutics Limited has announced the cessation of 3 million options due to unmet conditions as of September 30, 2024. The options, initially set to expire on December 8, 2025, were discontinued because the required conditions were not satisfied. This update may interest investors tracking the company’s capital structure and future prospects.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.